ArticleiScience2026
Progression of nipah virus infection in the African green monkey: Role of macrophages and dendritic cells in early virus spread.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
End-stage Nipah virus (NiV) infection has been well studied; however, little is known about the development of NiV disease. Here, 12 African green monkeys (AGM) were exposed to NiV and examined over 5 days to investigate NiV pathogenesis. DC-SIGN-positive immature dendritic cells in tonsil and alveolar macrophages were identified at 3 days postinfection (DPI) as early targets, implicating a critical role in the spread of NiV to other tissues. By 5 DPI, NiV spread to endothelium and respiratory epithelium, while fibrin was noted in blood vessels and alveolar spaces. NiV antigen was not detected in cells of CNS tissues from any AGM 3-5 DPI, indicating that neuroinvasion is a late event. NiV elicited a biphasic host response characterized by early consumption of coagulation factors followed by induction of interferon-stimulated cytokines/chemokines and endothelial activation markers. RNA-seq identified a robust, complement-associated immune response in tonsil, versus a muted, interferon-associated response in lung.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.